Transcription-dependent spreading of the Dal80 yeast GATA factor across the body of highly expressed genes

PLoS Genet. 2019 Feb 28;15(2):e1007999. doi: 10.1371/journal.pgen.1007999. eCollection 2019 Feb.

Abstract

GATA transcription factors are highly conserved among eukaryotes and play roles in transcription of genes implicated in cancer progression and hematopoiesis. However, although their consensus binding sites have been well defined in vitro, the in vivo selectivity for recognition by GATA factors remains poorly characterized. Using ChIP-Seq, we identified the Dal80 GATA factor targets in yeast. Our data reveal Dal80 binding to a large set of promoters, sometimes independently of GATA sites, correlating with nitrogen- and/or Dal80-sensitive gene expression. Strikingly, Dal80 was also detected across the body of promoter-bound genes, correlating with high expression. Mechanistic single-gene experiments showed that Dal80 spreading across gene bodies requires active transcription. Consistently, Dal80 co-immunoprecipitated with the initiating and post-initiation forms of RNA Polymerase II. Our work suggests that GATA factors could play dual, synergistic roles during transcription initiation and post-initiation steps, promoting efficient remodeling of the gene expression program in response to environmental changes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Chromatin Immunoprecipitation
  • DNA, Fungal / chemistry
  • DNA, Fungal / metabolism*
  • GATA Transcription Factors / metabolism*
  • Gene Expression Regulation, Fungal
  • Promoter Regions, Genetic*
  • RNA Polymerase II / metabolism
  • Repressor Proteins / metabolism*
  • Saccharomyces cerevisiae / genetics*
  • Saccharomyces cerevisiae Proteins / metabolism*
  • Sequence Analysis, RNA
  • Transcription, Genetic
  • Up-Regulation*

Substances

  • DAL80 protein, S cerevisiae
  • DNA, Fungal
  • GATA Transcription Factors
  • Repressor Proteins
  • Saccharomyces cerevisiae Proteins
  • RNA Polymerase II

Grants and funding

This work has benefited from the facilities and expertise of the NGS platform of Institut Curie, supported by the Agence Nationale de la Recherche (ANR-10-EQPX-03, ANR10-INBS-09-08) and the Canceropôle Ile-de-France. AM’s lab is supported by the Agence Nationale de la Recherche (DNA-Life) and the European Research Council (EpincRNA starting grant, DARK consolidator grant). Work by IG and ED is funded by the CoCoF and FNRS (FRFC 2.4547.11). Work by AR was funded by a FRIA fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.